We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Motif Bio Plc | LSE:MTFB | London | Ordinary Share | GB00BVVT4H71 | ORD 0.01P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.50 | 0.40 | 0.55 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
06/10/2017 13:35 | Thanks for bringing to our attention. I've just added further. | brucie5 | |
06/10/2017 13:26 | Merrill Lynch take a 5% stake!!!!!!!! | mirabeau | |
06/10/2017 11:54 | this share needs an antibiotic, it's plagued! | duckconfit | |
06/10/2017 07:55 | Links to Posters from today's RNS Efficacy Evaluation of Iclaprim in a Neutropenic Rat Lung Infection Model with Methicillin-Resistan Effects of Iclaprim and Trimethoprim on Exotoxin Production by Methicillin-resistan | timbo003 | |
06/10/2017 07:53 | >>>>> Yes that's odd, here's the link from Investegate anyway: . | timbo003 | |
06/10/2017 07:48 | yes - why doesn't it show here though | jrjr99 | |
06/10/2017 07:07 | RNS - more great news | mirabeau | |
05/10/2017 21:06 | has this been posted already? Vadim Alexandre, head of research at Northland Capital Partners, discusses with Proactive Motif Bio Plc's (LON:MTFB, NASDAQ: MTFB) lead drug, a next generation antibiotic, successfully negotiating a crucial final-stage clinical study. | maxwellsdemon | |
05/10/2017 18:24 | No placing, they had $29m at the interims, more than enough to get them through to approval and that will be the point to have the placing, probably near £1 or more, less dilutive. | value king | |
05/10/2017 17:39 | What's wrong with being in a share on aim for the long haul? I have no qualms sitting on my shares till year end.Buys showing up late again | kingkongtimmo | |
05/10/2017 16:27 | remember its all rigged, to think the instis will pay the same as us is naive in the extreme | duckconfit | |
05/10/2017 16:26 | doubt the insti's will have to buy in the market, they'll just get theirs in a discounted placing. mtfb's house broker will whisper in the ceo's ear 'what a great opportunity this is to tap the market for some cash' and them a nice fee. also lets the instis get in before any big rise. aimho. | duckconfit | |
05/10/2017 16:22 | U gotta buy a steady earner, dislike plugging intensely but RFX. should likely thrive, pharmas despite the hype still tremendously risky, better off investing in bloodstock judging by the strength of the yearling prices at Newmarket this week, unbelievably strong market, Thai bloke behind King Power( Leicester City) making a big splash! | bookbroker | |
05/10/2017 16:15 | everyone wants to make money on AIM - especially the MMs | pyglet | |
05/10/2017 15:56 | so much for the 'special relationship' | le mass du pap | |
05/10/2017 11:24 | Oh gawd, bullet ant has turned up here, he was on the AMP board shouting at everyone that the share price would close above 4p and look what happened there, suggest filter is used.... | enewman36 | |
05/10/2017 10:58 | That won't be the last increase in holding notice we see. Funds know fine well that this is now an obvious takeover target, or worst case massively de-risked as they find a partner. Buy and hold imo. | btfd | |
05/10/2017 10:22 | I TOLD Y'ALL IT WAS GOING TO RETRACE UP. LATER ON WE WILL DO BATTLE AT 52P. TOMORROW WILL THE FUN DAY ACTUALLY ON THE WAY TO 60P. BA STEALING IS GOOD | bullet ant | |
05/10/2017 10:10 | Not sure u a right | gerrym two |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions